Biophysical and transcriptomic characterization of LL-37-derived antimicrobial peptide targeting multidrug-resistant Escherichia coli and ESKAPE pathogens.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Biophysical and transcriptomic characterization of LL-37-derived antimicrobial peptide targeting multidrug-resistant Escherichia coli and ESKAPE pathogens.
- Published In:
- Scientific reports, 15(1), 36126 (2025)
- Authors:
- Eladl, Omar
- Database ID:
- RPEP-10830
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10830APA
Eladl, Omar. (2025). Biophysical and transcriptomic characterization of LL-37-derived antimicrobial peptide targeting multidrug-resistant Escherichia coli and ESKAPE pathogens.. Scientific reports, 15(1), 36126. https://doi.org/10.1038/s41598-025-22890-7
MLA
Eladl, Omar. "Biophysical and transcriptomic characterization of LL-37-derived antimicrobial peptide targeting multidrug-resistant Escherichia coli and ESKAPE pathogens.." Scientific reports, 2025. https://doi.org/10.1038/s41598-025-22890-7
RethinkPeptides
RethinkPeptides Research Database. "Biophysical and transcriptomic characterization of LL-37-der..." RPEP-10830. Retrieved from https://rethinkpeptides.com/research/eladl-2025-biophysical-and-transcriptomic-characterization
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.